Lack of clinically significant interaction between steady state tolvaptan and digoxin in healthy volunteers.

被引：2
|
作者：
Shoaf, SE [1 ]
Wang, Z [1 ]
Mallikaarjun, S [1 ]
Bricmont, P [1 ]
Bramer, SL [1 ]
机构：
[1] Otsuka MD Res Inst, Rockville, MD USA
来源：
CLINICAL PHARMACOLOGY & THERAPEUTICS | 2004年 / 75卷 / 02期
关键词：
D O I：
10.1016/j.clpt.2003.11.139
中图分类号：
R9 [药学];
学科分类号：
1007 ;
摘要：
引用
收藏
页码：P37 / P37
页数：1
相关论文
共 50 条
  • [21] Pharmacokinetic study on the interaction between cabergoline and clarithromycin in healthy volunteers.
    Nomura, T
    Zhang, J
    Nakatsuka, A
    Nomoto, M
    JOURNAL OF PHARMACOLOGICAL SCIENCES, 2003, 91 : 74P - 74P
  • [22] ASSESSMENT OF THE PHARMACOKINETIC INTERACTION BETWEEN FIMASARTAN AND LINAGLIPTIN IN HEALTHY VOLUNTEERS.
    Seong, S.
    Kang, W.
    Ohk, B.
    Kim, B.
    Gwon, M. -R.
    Cho, S.
    Lee, H.
    Yoon, Y. -R.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2019, 105 : S70 - S70
  • [23] Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers
    Sabo, John P.
    Cong, Xiuyu
    Kraft, Michael-Friedrich
    Wallace, Lacey
    Castles, Mark A.
    Mauss, Stefan
    MacGregor, Thomas R.
    EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 67 (03) : 277 - 281
  • [24] Lack of a pharmacokinetic interaction between steady-state tipranavir/ritonavir and single-dose valacyclovir in healthy volunteers
    John P. Sabo
    Xiuyu (Julie) Cong
    Michael-Friedrich Kraft
    Lacey Wallace
    Mark A. Castles
    Stefan Mauss
    Thomas R. MacGregor
    European Journal of Clinical Pharmacology, 2011, 67 : 277 - 281
  • [25] Pharmacokinetic interaction between eszopiclone and ketoconazole in healthy volunteers at steady state.
    Anderson, AJ
    Maier, G
    Skolly, SM
    PHARMACOTHERAPY, 2005, 25 (03): : 474 - 474
  • [26] Lack of clinically significant pharmacokinetic interactions between zonisamide and lamotrigine at steady state in patients with epilepsy
    Levy, RH
    Ragueneau-Majlessi, I
    Brodie, MJ
    Smith, DE
    Shah, D
    Pan, WJ
    THERAPEUTIC DRUG MONITORING, 2005, 27 (02) : 193 - 198
  • [27] Randomized, single-blind, crossover, interaction study of teriparatide and digoxin pharmacodynamics in healthy volunteers.
    Benson, CT
    Voelker, JR
    JOURNAL OF CLINICAL PHARMACOLOGY, 2002, 42 (09): : 1052 - 1052
  • [28] ABSENCE OF PHARMACOKINETIC INTERACTION BETWEEN ROFLUMILAST AND DIGOXIN IN HEALTHY VOLUNTEERS
    Eckermann, G.
    Huennemeyer, A.
    Nassr, N.
    Lahu, G.
    Bethke, T.
    BRITISH JOURNAL OF CLINICAL PHARMACOLOGY, 2010, 70 : 11 - 11
  • [29] Substantial pharmacokinetic interaction between digoxin and ritonavir in healthy volunteers
    Ding, R
    Tayrouz, Y
    Riedel, KD
    Burhenne, J
    Weiss, J
    Mikus, G
    Haefeli, WE
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2004, 76 (01) : 73 - 84
  • [30] In Vitro P-Glycoprotein Interactions and Steady-State Pharmacokinetic Interactions Between Tolvaptan and Digoxin in Healthy Subjects
    Shoaf, Susan E.
    Ohzone, Yoshihiro
    Ninomiya, Shin-ichi
    Furukawa, Masayuki
    Bricmont, Patricia
    Kashiyama, Eiji
    Mallikaarjun, Suresh
    JOURNAL OF CLINICAL PHARMACOLOGY, 2011, 51 (05): : 761 - 769
12345